micronor
norethisterone -
colocynthis- citrullus colocynthis fruit pulp pellet
washington homeopathic products - colocynthis - to relieve the symptoms of colic-like pain. indications: colocynthis colic-like pain if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.
colocynthis- citrullus colocynthis fruit pulp liquid
washington homeopathic products - colocynthis - to relieve the symptoms of colic-like pain. indications: colocynthis colic-like pain if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.
nucynta- tapentadol hydrochloride tablet, film coated
lake erie medical dba quality care products llc - tapentadol hydrochloride (unii: 71204kii53) (tapentadol - unii:h8a007m585) - tapentadol 100 mg - like other drugs with mu-opioid agonist activity, nucynta® is contraindicated in patients with significant respiratory depression in unmonitored settings or the absence of resuscitative equipment. nucynta® is also contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment [see warnings and precautions (5.1)] . like drugs with mu-opioid agonist activity, nucynta® is contraindicated in any patient who has or is suspected of having paralytic ileus. nucynta® is contraindicated in patients who are receiving monoamine oxidase (mao) inhibitors or who have taken them within the last 14 days due to potential additive effects on norepinephrine levels which may result in adverse cardiovascular events [see drug interactions (7.4)] . pregnancy category c. tapentadol hcl was evaluated for teratogenic effects in pregnant rats and rabbits following intravenous and subcutaneous exposure during the period of embryofetal organogenesis. w
nucynta- tapentadol hydrochloride tablet, film coated
lake erie medical dba quality care products llc - tapentadol hydrochloride (unii: 71204kii53) (tapentadol - unii:h8a007m585) - like other drugs with mu-opioid agonist activity, nucynta® is contraindicated in patients with significant respiratory depression in unmonitored settings or the absence of resuscitative equipment. nucynta® is also contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment [see warnings and precautions (5.1)] . like drugs with mu-opioid agonist activity, nucynta® is contraindicated in any patient who has or is suspected of having paralytic ileus. nucynta® is contraindicated in patients who are receiving monoamine oxidase (mao) inhibitors or who have taken them within the last 14 days due to potential additive effects on norepinephrine levels which may result in adverse cardiovascular events [see drug interactions (7.4)] . pregnancy category c. tapentadol hcl was evaluated for teratogenic effects in pregnant rats and rabbits following intravenous and subcutaneous exposure during the period of embryofetal organogenesis. w
apocynum cannabinum pellet
rxhomeo private limited d.b.a. rxhomeo, inc - apocynum cannabinum root (unii: 2f92409l9z) (apocynum cannabinum root - unii:2f92409l9z) - apocynum cannabinum root 3 [hp_x] - rheumatism condition listed above or as directed by the physician
apocynum cannabinum tablet
rxhomeo private limited d.b.a. rxhomeo, inc - apocynum cannabinum root (unii: 2f92409l9z) (apocynum cannabinum root - unii:2f92409l9z) - apocynum cannabinum root 3 [hp_x] - rheumatism condition listed above or as directed by the physician
nucynta- tapentadol hydrochloride tablet, film coated
lake erie medical dba quality care products llc - tapentadol (unii: h8a007m585) (tapentadol - unii:h8a007m585) - tapentadol 50 mg - 1 indications and usage nucynta® (tapentadol) is indicated for the relief of moderate to severe acute pain in patients 18 years of age or older. 4 contraindications 4.1 impaired pulmonary function like other drugs with mu-opioid agonist activity, nucynta® is contraindicated in patients with significant respiratory depression in unmonitored settings or the absence of resuscitative equipment. nucynta® is also contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment [see warnings and precautions (5.1)] . 4.2 paralytic ileus like drugs with mu-opioid agonist activity, nucynta® is contraindicated in any patient who has or is suspected of having paralytic ileus. 4.3 monoamine oxidase inhibitors nucynta® is contraindicated in patients who are receiving monoamine oxidase (mao) inhibitors or who have taken them within the last 14 days due to potential additive effects on norepinephrine levels which ma
nucynta- tapentadol hydrochloride tablet, film coated
physicians total care, inc. - tapentadol hydrochloride (unii: 71204kii53) (tapentadol - unii:h8a007m585) - tapentadol hydrochloride 50 mg - nucynta® (tapentadol) is indicated for the relief of moderate to severe acute pain in patients 18 years of age or older. enter section text here like other drugs with mu-opioid agonist activity, nucynta® is contraindicated in patients with significant respiratory depression in unmonitored settings or the absence of resuscitative equipment. nucynta® is also contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment [see warnings and precautions (5.1)] . like drugs with mu-opioid agonist activity, nucynta® is contraindicated in any patient who has or is suspected of having paralytic ileus. nucynta® is contraindicated in patients who are receiving monoamine oxidase (mao) inhibitors or who have taken them within the last 14 days due to potential additive effects on norepinephrine levels which may result in adverse cardiovascular events [see drug interactions (7.4)] . enter section text here pregnancy category c
nucynta- tapentadol hydrochloride tablet, film coated
stat rx usa - tapentadol hydrochloride (unii: 71204kii53) (tapentadol - unii:h8a007m585) - tapentadol 50 mg - nucynta™ (tapentadol) is indicated for the relief of moderate to severe acute pain in patients 18 years of age or older. like other drugs with mu-opioid agonist activity, nucynta™ is contraindicated in patients with significant respiratory depression in unmonitored settings or the absence of resuscitative equipment. nucynta™ is also contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment [see warnings and precautions (5.1)] . like drugs with mu-opioid agonist activity, nucynta™ is contraindicated in any patient who has or is suspected of having paralytic ileus. nucynta™ is contraindicated in patients who are receiving monoamine oxidase (mao) inhibitors or who have taken them within the last 14 days due to potential additive effects on norepinephrine levels which may result in adverse cardiovascular events [see drug interactions (7.4)] . pregnancy category c. tapentadol hcl was evaluated for teratogenic effects in pregna